(Q37586257)

21 August 2017

1 reference

title

Radiotherapy for metastatic brain tumors (English)

1 reference

adaptive radiation therapy

21 August 2017

main subject

0 references

1

Yuta Shibamoto

1 reference

21 August 2017

Chikao Sugie

2

1 reference

21 August 2017

Hiromitsu Iwata

series ordinal

3

1 reference

21 August 2017

publication date

25 August 2009

1 reference

International Journal of Clinical Oncology

21 August 2017

published in

1 reference

21 August 2017

volume

14

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

281-288

1 reference

Improvement in quality of survival following whole-brain irradiation for brain metastasis.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Radiation-induced dementia in patients cured of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Memory function before and after whole brain radiotherapy in patients with and without brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Hippocampal neuron number is unchanged 1 year after fractionated whole-brain irradiation at middle age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Neural stem cells: implications for the conventional radiotherapy of central nervous system malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

Neural stem cell-preserving external-beam radiotherapy of central nervous system malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-009-0915-2

The role of radiation therapy in the treatment of brain metastases

21 January 2018

1 reference

12 December 2020

Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

1 reference

12 December 2020

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European

1 reference

12 December 2020

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

1 reference

12 December 2020

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy

1 reference

12 December 2020

Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial

1 reference

12 December 2020

Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase

1 reference

12 December 2020

RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database

1 reference

12 December 2020

The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer

1 reference

12 December 2020

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

1 reference

12 December 2020

Ionizing radiation-induced apoptosis of proliferating stem cells in the dentate gyrus of the adult rat hippocampus

1 reference

12 December 2020

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

1 reference

12 December 2020

[Assessment of cognitive function after preventive and therapeutic whole brain irradiation using neuropsychological testing].

1 reference

12 December 2020

Symptom response after palliative radiotherapy for patients with brain metastases.

1 reference

12 December 2020

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study

1 reference

12 December 2020

Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT

1 reference

12 December 2020

Neurocognitive dysfunction in cancer patients.

1 reference

12 December 2020

Prognostic factors in patients with brain metastases from lung carcinoma

1 reference

12 December 2020

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases

1 reference

12 December 2020

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

1 reference

12 December 2020

What is the optimal therapy of brain metastases?

1 reference

12 December 2020

Roentgen-ray therapy of cerebral metastases.

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates

1 reference

12 December 2020

Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397)

1 reference

12 December 2020

Whole-brain radiotherapy in the management of brain metastasis

1 reference

12 December 2020

Aberrant methylation and loss of expression of O-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma.

1 reference

12 December 2020

Helical tomotherapy for brain metastases: dosimetric evaluation of treatment plans and early clinical results

1 reference

12 December 2020

Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases

1 reference

12 December 2020

The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology group

1 reference

12 December 2020

Biological effect of intermittent radiation exposure in vivo: recovery from sublethal damage versus reoxygenation

1 reference

12 December 2020

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

1 reference

12 December 2020

Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites

1 reference

12 December 2020

Radiosurgery for metastatic brain tumors

1 reference

12 December 2020

The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs

1 reference

12 December 2020

Prognosis of patients treated for intracranial metastases with whole-brain irradiation

1 reference

12 December 2020

Intracerebral metastases in solid-tumor patients: Natural history and results of treatment

1 reference

12 December 2020

Radiation therapy of cerebral metastases: a randomized prospective clinical trial

1 reference

12 December 2020

Radiation injury and neurogenesis

1 reference

12 December 2020

Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points

1 reference

12 December 2020

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases

1 reference

12 December 2020

10.1007/S10147-009-0915-2

Identifiers

DOI

1 reference

21 August 2017

1 reference